Skip to content

Effect of Homeopathic Medicines in Patients with Chronic Fatigue Syndrome

EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN MANAGEMENT OF CHRONIC FATIGUE SYNDROME - AN EXPERIMENTAL UNCONTROLLED STUDY - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107621
Enrollment
30
Registered
2026-04-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R531- Weakness

Interventions

Intervention1: Individualized homeopathic medicines: These remedies are selected based on the totality of symptoms, taking into account the patients specific constitution, miasm, and temperament. Medi

Sponsors

Dr Neha Dnyaneshwar Shahakar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.only patients having persistence of symptoms of chronic fatigue syndrome above 6 months are included for this study 2.patients of different socio-economic status and religion will be included 3.patients of age group 18yrs irrespective of sex are included for this study 4.patients willing to participate in clinical trial/ study with written consent 5. Pre diagnosed cases

Exclusion criteria

Exclusion criteria: 1.Immunocompromised patients and patients with complicated conditions that could confound results. 2.Patients undergoing any other form of treatment or medication for CFS 3.pregnant and lactating women 4.patients with gross pathological conditions 5.patients with other fatal and systemic complications 6. Hypersensitivity Reactions

Design outcomes

Primary

MeasureTime frame
The primary outcome is the change in fatigue severity as measured by the 0-5 Rating Scale for Chronic Fatigue Syndrome. Assessments will be conducted at Baseline (Day 0), and subsequently at every follow-up visit (approximately every 4 weeks) throughout the 18-month study duration to monitor treatment efficacyTimepoint: Assessments will be recorded at Baseline (Day 0), followed by regular intervals every 15 to 30 days during follow-up visits, with a final evaluation at the completion of the 18-month study period.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Neha Dnyaneshwar Shahakar

Sonajirao Kshirsagar Homoeopathic Medical College Beed 431122

dramitbhasme@gmail.com8600961111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026